Cargando…
Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations
With the aim of developing an in vitro model for the bioavailability (BA) prediction of drugs, we focused on the study of levonorgestrel (LVN) released by 1.5 mg generic and brand-name tablets. The developed method consisted in combining a standard dissolution test with an optimized parallel artific...
Autores principales: | De Simone, A., Davani, L., Montanari, S., Tumiatti, V., Avanessian, S., Testi, F., Andrisano, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597939/ https://www.ncbi.nlm.nih.gov/pubmed/34805090 http://dx.doi.org/10.3389/fchem.2021.741876 |
Ejemplares similares
-
Evaluation of Bioequivalence of Two Oral Formulations of Olanzapine
por: Singhal, R., et al.
Publicado: (2011) -
Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation
por: Yang, A-Young, et al.
Publicado: (2023) -
Glycogen Synthase
Kinase 3β: A New Gold Rush
in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective
por: De Simone, Angela, et al.
Publicado: (2020) -
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate
por: Hussaini, Azra, et al.
Publicado: (2017) -
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy
por: Tolbert, Dwain, et al.
Publicado: (2015)